GPBAR1 and metabolic dysfunction-associated steatotic liver disease: These findings are in line with previous studies on the role of DCA in protein catabolism and energy consumption through TGR5 activation, thus suggesting it as a potential biomarker of sarcopenia, arising in patients with advanced non-alcoholic fatty liver disease (NAFLD) [37].